| 5-FU | 5-Fluorouracil |
| AChE | Acetylcholinesterase |
| ACN | Acetonitrile |
| AD | Alzheimer Disease |
| AMP | Antimicrobial peptide |
| BBB | Blood brain barrier |
| CPP | cell penetrating peptide |
| CuAAC | Copper-catalyzed azide−alkyne coupling |
| DAD | Diode-array detector |
| DIEA | Diisopropylethylamine |
| DMF | N,N-dimethylformamide |
| ESI-IT MS | Electrospray ionization-ion trap mass spectrometry |
| FDA | Food and Drug Administration |
| HOBt | 1-hydroxybenzotriazole |
| HPLC | High performance liquid chromatography |
| LC-MS | Liquid chromatography–mass spectrometry |
| MALDI-TOF/TOF | Matrix assisted desorption/ionization mass spectrometry |
| MAP | model amphipathic peptide |
| MTT | 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide |
| MW | Microwave |
| NaAsc | Sodium ascorbate |
| SD | Standard deviation |
| SEM | Standard error of the mean |
| SPPS | solid-phase peptide synthesis |
| TEER | Trans-epithelial electrical resistance |
| TFA | Trifluoroacetic acid |